Cargando…
Galectin-3 expression in donor T cells reduces GvHD severity and lethality after allogeneic hematopoietic cell transplantation
Abundant donor cytotoxic T cells that attack normal host organs remain a major problem for patients receiving allogeneic hematopoietic cell transplantation (allo-HCT). Despite an increase in our knowledge of the pathobiology of acute graft versus host disease (aGvHD), the mechanisms regulating the p...
Autores principales: | Mohammadpour, Hemn, Tsuji, Takemasa, MacDonald, Cameron R., Sarow, Joseph L., Rosenheck, Hanna, Daneshmandi, Saeed, Choi, Jee Eun, Qiu, Jingxin, Matsuzaki, Junko, Witkiewicz, Agnieszka K., Attwood, Kristopher, Blazar, Bruce R., Odunsi, Kunle, Repasky, Elizabeth A., McCarthy, Philip L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10116561/ https://www.ncbi.nlm.nih.gov/pubmed/36924493 http://dx.doi.org/10.1016/j.celrep.2023.112250 |
Ejemplares similares
-
Inflammasome effects in GvHD
por: Koehn, Brent H., et al.
Publicado: (2015) -
Editorial: Interferons and GvHD
por: Kim, Boram, et al.
Publicado: (2022) -
Chronic GvHD NIH Consensus Project Biology Task Force: evolving path to personalized treatment of chronic GvHD
por: Buxbaum, Nataliya P., et al.
Publicado: (2022) -
Antibody- and aptamer-strategies for GvHD prevention
por: Oelkrug, Christopher, et al.
Publicado: (2015) -
Established and Emerging Treatments of Skin GvHD
por: Link-Rachner, Cornelia S., et al.
Publicado: (2022)